MISSION Therapeutics raised €11M in a funding round in Oct 2025. The company is based in Cambridge, UK. Investors in the round: IP Group, Pfizer Venture Investments, Roche Venture Fund and 3 others. Data as of 6 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
